• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA修复因子RAD18和DNA聚合酶Polκ赋予对致癌性DNA复制应激的耐受性。

DNA repair factor RAD18 and DNA polymerase Polκ confer tolerance of oncogenic DNA replication stress.

作者信息

Yang Yang, Gao Yanzhe, Mutter-Rottmayer Liz, Zlatanou Anastasia, Durando Michael, Ding Weimin, Wyatt David, Ramsden Dale, Tanoue Yuki, Tateishi Satoshi, Vaziri Cyrus

机构信息

Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.

Oncology Center, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

出版信息

J Cell Biol. 2017 Oct 2;216(10):3097-3115. doi: 10.1083/jcb.201702006. Epub 2017 Aug 23.

DOI:10.1083/jcb.201702006
PMID:28835467
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5626543/
Abstract

The mechanisms by which neoplastic cells tolerate oncogene-induced DNA replication stress are poorly understood. Cyclin-dependent kinase 2 (CDK2) is a major mediator of oncogenic DNA replication stress. In this study, we show that CDK2-inducing stimuli (including Cyclin E overexpression, oncogenic RAS, and WEE1 inhibition) activate the DNA repair protein RAD18. CDK2-induced RAD18 activation required initiation of DNA synthesis and was repressed by p53. RAD18 and its effector, DNA polymerase κ (Polκ), sustained ongoing DNA synthesis in cells harboring elevated CDK2 activity. RAD18-deficient cells aberrantly accumulated single-stranded DNA (ssDNA) after CDK2 activation. In RAD18-depleted cells, the G2/M checkpoint was necessary to prevent mitotic entry with persistent ssDNA. and cells were highly sensitive to the WEE1 inhibitor MK-1775 (which simultaneously activates CDK2 and abrogates the G2/M checkpoint). Collectively, our results show that the RAD18-Polκ signaling axis allows tolerance of CDK2-mediated oncogenic stress and may allow neoplastic cells to breach tumorigenic barriers.

摘要

肿瘤细胞耐受致癌基因诱导的DNA复制应激的机制目前尚不清楚。细胞周期蛋白依赖性激酶2(CDK2)是致癌性DNA复制应激的主要介质。在本研究中,我们发现诱导CDK2的刺激因素(包括细胞周期蛋白E过表达、致癌性RAS和WEE1抑制)可激活DNA修复蛋白RAD18。CDK2诱导的RAD18激活需要DNA合成的起始,并受到p53的抑制。RAD18及其效应因子DNA聚合酶κ(Polκ)在CDK2活性升高的细胞中维持正在进行的DNA合成。CDK2激活后,RAD18缺陷细胞异常积累单链DNA(ssDNA)。在RAD18缺失的细胞中,G2/M期检查点对于防止携带持续性ssDNA进入有丝分裂是必要的。而且,这些细胞对WEE1抑制剂MK-1775(其同时激活CDK2并消除G2/M期检查点)高度敏感。总之,我们的结果表明,RAD18-Polκ信号轴使细胞能够耐受CDK2介导的致癌应激,并可能使肿瘤细胞突破致瘤屏障。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f83/5626543/8c5a8a050500/JCB_201702006_Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f83/5626543/9d150cabf158/JCB_201702006_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f83/5626543/b746210202a1/JCB_201702006_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f83/5626543/917ee9b2723c/JCB_201702006_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f83/5626543/b3566e907d1c/JCB_201702006_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f83/5626543/e7a3bedf9449/JCB_201702006_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f83/5626543/7560cc87647f/JCB_201702006_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f83/5626543/589f6b704811/JCB_201702006_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f83/5626543/8c5a8a050500/JCB_201702006_Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f83/5626543/9d150cabf158/JCB_201702006_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f83/5626543/b746210202a1/JCB_201702006_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f83/5626543/917ee9b2723c/JCB_201702006_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f83/5626543/b3566e907d1c/JCB_201702006_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f83/5626543/e7a3bedf9449/JCB_201702006_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f83/5626543/7560cc87647f/JCB_201702006_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f83/5626543/589f6b704811/JCB_201702006_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f83/5626543/8c5a8a050500/JCB_201702006_Fig8.jpg

相似文献

1
DNA repair factor RAD18 and DNA polymerase Polκ confer tolerance of oncogenic DNA replication stress.DNA修复因子RAD18和DNA聚合酶Polκ赋予对致癌性DNA复制应激的耐受性。
J Cell Biol. 2017 Oct 2;216(10):3097-3115. doi: 10.1083/jcb.201702006. Epub 2017 Aug 23.
2
Rad18 regulates DNA polymerase kappa and is required for recovery from S-phase checkpoint-mediated arrest.Rad18调节DNA聚合酶κ,是从S期检查点介导的停滞中恢复所必需的。
Mol Cell Biol. 2006 May;26(9):3527-40. doi: 10.1128/MCB.26.9.3527-3540.2006.
3
WEE1 kinase limits CDK activities to safeguard DNA replication and mitotic entry.WEE1 激酶限制 CDK 活性以保护 DNA 复制和有丝分裂进入。
Mutat Res. 2020 Jan-Apr;819-820:111694. doi: 10.1016/j.mrfmmm.2020.111694. Epub 2020 Feb 25.
4
A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase.由于S期CDK2激活,一部分癌细胞系对Chk1抑制剂MK-8776单药治疗极为敏感。
Oncotarget. 2016 Jan 12;7(2):1380-94. doi: 10.18632/oncotarget.6364.
5
Temporally distinct post-replicative repair mechanisms fill PRIMPOL-dependent ssDNA gaps in human cells.在人类细胞中,时间上不同的复制后修复机制填补了 PRIMPOL 依赖性单链 DNA 缺口。
Mol Cell. 2021 Oct 7;81(19):4026-4040.e8. doi: 10.1016/j.molcel.2021.09.013.
6
Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma.联合抑制Chk1和Wee1作为套细胞淋巴瘤的一种新治疗策略。
Oncotarget. 2015 Feb 20;6(5):3394-408. doi: 10.18632/oncotarget.2583.
7
Molecular Pathways: Targeting the Protein Kinase Wee1 in Cancer.分子途径:在癌症中靶向蛋白激酶 Wee1。
Clin Cancer Res. 2017 Aug 15;23(16):4540-4544. doi: 10.1158/1078-0432.CCR-17-0520. Epub 2017 Apr 25.
8
Increased activity of both CDK1 and CDK2 is necessary for the combinatorial activity of WEE1 inhibition and cytarabine.CDK1和CDK2活性的增加对于WEE1抑制和阿糖胞苷的联合活性是必需的。
Leuk Res. 2018 Jan;64:30-33. doi: 10.1016/j.leukres.2017.11.004. Epub 2017 Nov 11.
9
Wee1 kinase as a target for cancer therapy.Wee1 激酶作为癌症治疗的靶点。
Cell Cycle. 2013 Oct 1;12(19):3159-64. doi: 10.4161/cc.26062. Epub 2013 Aug 26.
10
Targeting WEE1 Kinase in Cancer.靶向癌症中的 WEE1 激酶。
Trends Pharmacol Sci. 2016 Oct;37(10):872-881. doi: 10.1016/j.tips.2016.06.006. Epub 2016 Jul 14.

引用本文的文献

1
The RING finger E3 ligase RNF25 protects DNA replication forks independently of its canonical roles in ubiquitin signaling.环状结构域E3连接酶RNF25独立于其在泛素信号传导中的经典作用来保护DNA复制叉。
Nat Commun. 2025 Aug 5;16(1):7214. doi: 10.1038/s41467-025-62368-8.
2
DIFFERENTIAL ROLES OF RAD18 IN REPRESSING CARCINOGEN- AND ONCOGENE-DRIVEN MUTAGENESIS .RAD18在抑制致癌物和癌基因驱动的诱变中的不同作用
bioRxiv. 2025 Jul 4:2025.06.30.662411. doi: 10.1101/2025.06.30.662411.
3
MRN-CtIP, EXO1, and DNA2-WRN/BLM act bidirectionally to process DNA gaps in PARPi-treated cells without strand cleavage.

本文引用的文献

1
Proteomic Profiling Reveals a Specific Role for Translesion DNA Polymerase η in the Alternative Lengthening of Telomeres.蛋白质组学分析揭示了跨损伤DNA聚合酶η在端粒替代延长中的特定作用。
Cell Rep. 2016 Nov 8;17(7):1858-1871. doi: 10.1016/j.celrep.2016.10.048.
2
Rad18-dependent SUMOylation of human specialized DNA polymerase eta is required to prevent under-replicated DNA.Rad18 依赖性 SUMOylation 修饰人源特异性 DNA 聚合酶 eta 对于防止复制不完全的 DNA 至关重要。
Nat Commun. 2016 Nov 4;7:13326. doi: 10.1038/ncomms13326.
3
Human Translesion Polymerase κ Exhibits Enhanced Activity and Reduced Fidelity Two Nucleotides from G-Quadruplex DNA.
MRN-CtIP、EXO1和DNA2-WRN/BLM双向作用,在聚(ADP-核糖)聚合酶抑制剂(PARPi)处理的细胞中处理DNA缺口而不产生链断裂。
Genes Dev. 2025 May 2;39(9-10):582-602. doi: 10.1101/gad.352421.124.
4
TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stress.TRIP13保护胰腺癌细胞免受内在的和治疗诱导的DNA复制应激。
NAR Cancer. 2025 Mar 20;7(1):zcaf009. doi: 10.1093/narcan/zcaf009. eCollection 2025 Mar.
5
Pathological modulation of genome maintenance by cancer/testes antigens (CTAs).癌症/睾丸抗原(CTAs)对基因组维持的病理调控
DNA Repair (Amst). 2025 Mar;147:103818. doi: 10.1016/j.dnarep.2025.103818. Epub 2025 Feb 16.
6
TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stress.TRIP13保护胰腺癌细胞免受内在及治疗诱导的DNA复制应激。
bioRxiv. 2025 Jan 27:2025.01.26.634889. doi: 10.1101/2025.01.26.634889.
7
The RING Finger E3 Ligase RNF25 Protects DNA Replication Forks Independently of its Canonical Roles in Ubiquitin Signaling.环状结构域E3连接酶RNF25独立于其在泛素信号传导中的典型作用保护DNA复制叉。
bioRxiv. 2025 Jan 9:2025.01.09.632184. doi: 10.1101/2025.01.09.632184.
8
Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review).针对 Hippo 通路以预防来自肺部的放射性耐药脑转移 (综述)。
Int J Oncol. 2024 Jul;65(1). doi: 10.3892/ijo.2024.5656. Epub 2024 May 24.
9
Adaptive use of error-prone DNA polymerases provides flexibility in genome replication during tumorigenesis.易错 DNA 聚合酶的适应性利用为肿瘤发生过程中的基因组复制提供了灵活性。
Cancer Sci. 2024 Jul;115(7):2125-2137. doi: 10.1111/cas.16188. Epub 2024 Apr 23.
10
The DNA Damage Response (DDR) landscape of endometrial cancer defines discrete disease subtypes and reveals therapeutic opportunities.子宫内膜癌的DNA损伤反应(DDR)格局定义了不同的疾病亚型并揭示了治疗机会。
NAR Cancer. 2024 Apr 8;6(2):zcae015. doi: 10.1093/narcan/zcae015. eCollection 2024 Jun.
人跨损伤聚合酶κ在距G-四链体DNA两个核苷酸处表现出增强的活性和降低的保真度。
Biochemistry. 2016 Sep 20;55(37):5218-29. doi: 10.1021/acs.biochem.6b00374. Epub 2016 Sep 7.
4
Pathological trans-lesion synthesis in cancer.癌症中的病理性跨损伤合成
Cell Cycle. 2016 Nov 16;15(22):3005-3006. doi: 10.1080/15384101.2016.1214045. Epub 2016 Jul 27.
5
Essential Roles for Polymerase θ-Mediated End Joining in the Repair of Chromosome Breaks.聚合酶θ介导的末端连接在染色体断裂修复中的重要作用
Mol Cell. 2016 Aug 18;63(4):662-673. doi: 10.1016/j.molcel.2016.06.020. Epub 2016 Jul 21.
6
A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis.MAGE-A4 在跨损伤合成中的致癌细胞新功能。
Nat Commun. 2016 Jul 5;7:12105. doi: 10.1038/ncomms12105.
7
Rad18 confers hematopoietic progenitor cell DNA damage tolerance independently of the Fanconi Anemia pathway in vivo.Rad18在体内独立于范可尼贫血途径赋予造血祖细胞DNA损伤耐受性。
Nucleic Acids Res. 2016 May 19;44(9):4174-88. doi: 10.1093/nar/gkw072. Epub 2016 Feb 15.
8
A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase.由于S期CDK2激活,一部分癌细胞系对Chk1抑制剂MK-8776单药治疗极为敏感。
Oncotarget. 2016 Jan 12;7(2):1380-94. doi: 10.18632/oncotarget.6364.
9
Replication of Structured DNA and its implication in epigenetic stability.结构化DNA的复制及其对表观遗传稳定性的影响。
Front Genet. 2015 Jun 16;6:209. doi: 10.3389/fgene.2015.00209. eCollection 2015.
10
Regulation of Rad6/Rad18 Activity During DNA Damage Tolerance.DNA损伤耐受过程中Rad6/Rad18活性的调控
Annu Rev Biophys. 2015;44:207-28. doi: 10.1146/annurev-biophys-060414-033841.